Reagent Parameters for BS200/220 Chemistry Analyzers

Linearity
Pri. Sec. S R1 R2 Linear Reac. Time Incuba. Substrate Antigen
No, Reac. Type Direction Unit Precision Range Limit Rule
Wave Wave （µl） （µl） （µl） Limit Time Limit excess
From To Low Up
ALT 401 Kinetic Decrease U/L 0.1 340 405 10 200 50 0.2 4 15 19 4800 / 4 1000 Two-point linear
AST 402 Kinetic Decrease U/L 0.1 340 405 10 200 50 / 4 15 19 5700 / 4 800 Two- point linear
ALP 403 Kinetic Increase U/L 0.1 405 546 4 200 50 0.2 4 15 4 26400 / 5 800 Two- point linear
γ-GT 404 Kinetic Increase U/L 0.1 405 546 20 200 50 0.2 4 15 4 19800 / 4 650 Two- point linear
TP 408 Endpoint Increase g/L 0.1 546 630 4 200 / / 0 38 / / / 2 120 Two- point linear
TP Ⅱ 486 Endpoint Increase g/L 0.01 546 670 4 200 50 / -1 19 19 / / 2 120 Two- point linear
ALB 409 Endpoint Increase g/L 0.1 578 510 3 300 / / 0 19 / / / 3 60 Two- point linear
ALB II 483 Endpoint Increase g/L 0.1 630 670 3 300 / / 0 19 / / / 3 60 Two- point linear
T-Bil-V 406 Endpoint Decrease μmol/L 0.01 450 546 11 308 77 / -1 19 19 / / 2 684 Two- point linear
D-Bil-V 407 Endpoint Decrease μmol/L 0.01 450 546 7 196 49 / -1 19 19 / / 1 430 Two- point linear
T-Bil-DⅡ 474 Endpoint Increase μmol/L 0.01 546 630 3 200 50 / -1 19 19 / / 1.7 600 Two- point linear
D-Bil-DⅡ 475 Endpoint Increase μmol/L 0.01 546 670 16 160 40 / -1 19 19 / / 1 260 Two- point linear
TBA 432 Kinetic Increase μmol/L 0.1 405 510 4 270 90 0.2 4 15 19 27600 / 2 180 Two- point linear
PA 431 Endpoint Increase mg/L 0.1 340 / 7 200 75 / -1 19 19 / / 10 800 Spline
ADA 436 Kinetic Increase U/L 0.01 546 / 5 180 90 0.2 11 19 19 / / 1 200 Two- point linear
5′-NT 437 Kinetic Increase U/L 0.01 546 / 10 180 90 0.2 11 19 19 / / 0.5 300 Two- point linear
CHE 452 Kinetic Decrease U/L 0 405 670 4 250 50 0.2 6 15 40 / / 400 20000 Two- point linear
UA 412 Endpoint Increase μmol/L 0.1 546 670 5 240 60 / -1 19 19 / / 20.8 1500 Two- point linear
UREA 413 Kinetic Decrease mmol/L 0.01 340 670 4.5 300 75 / 6 13 8 8000 / 0.9 40 Two- point linear
CREA-J 410 Fixed Time Increase μmol/L 0.1 510 670 18 180 180 / 2 10 19 26000 / 9 2420 Two- point linear
CREA-S 411 Endpoint Increase μmol/L 0.1 546 670 6 180 60 / -1 19 19 / / 10 7000 Two- point linear
TPUC 479 Endpoint Increase mg/L 0.1 630 670 4 200 / / 0 19 / / / 20 2000 Two- point linear
Glu-God 415 Endpoint Increase mmol/L 0.01 510 670 3 240 60 / -1 38 19 / / 0.3 25 Two- point linear
Glu-HK 414 Endpoint Increase mmol/L 0.01 340 670 3 250 125 / -1 19 19 / / 0.6 33 Two- point linear
FUN 454 Kinetic Increase μmol/L 0.1 546 670 20 200 50 0.2 16 23 16 / / 5 1000 Two- point linear
CysC 433 Endpoint Decrease mg/L 0.001 546 670 3 240 60 / 1 19 19 / / 0.2 8 Spline
Hb 455 Endpoint Increase μmol/L 0.1 510 670 12 180 / / 0 19 / / / / 310 Two- point linear

1/3
 Linearity
Pri. Sec. S R1 R2 Linear Reac. Time Incuba. Substrate Antigen
No, Reac. Type Direction Unit Precision Range Limit Rule
Wave Wave （µl） （µl） （µl） Limit Time Limit excess
From To Low Up
HbA1C 446 Endpoint Increase μmol/L 0.1 670 / 12 180 60 / -1 19 19 / / / / Two- point linear
TC 416 Endpoint Increase mmol/L 0.01 510 670 3 300 / / 0 19 / / / 0.1 20 Two- point linear
TG 417 Endpoint Increase mmol/L 0.01 510 670 3 300 / / 0 38 / / / 0.1 12.5 Two- point linear
HDL-C 421 Endpoint Increase mmol/L 0.01 578 670 3 225 75 / -1 19 19 / / 0.05 6 Two- point linear
LDL-C 420 Endpoint Increase mmol/L 0.01 578 670 3 225 75 / -1 19 19 / / 0.05 20 Two- point linear
ApoA1 418 Endpoint Increase g/L 0.01 340 / 3 300 100 / -1 19 19 / / 0.2 2.3 Logit 5P
ApoB 419 Endpoint Increase g/L 0.01 340 / 3 300 100 / -1 19 19 / / 0.2 2.2 Logit 5P
Lp(a) 430 Endpoint Increase mg/L 0.01 340 / 18 300 30 / -1 19 19 / / 40 1000 Logit 4P
Lp(a) Ⅱ 484 Endpoint Increase nmol/L 0.01 630 / 2 180 45 / 1 19 19 / / 7 240 Spline
HCY II 480 Kinetic Decrease μmol/l 0.01 340 405 10 185 50 / 10 18 16 / / 3 50 Spline
LDH 427 Kinetic Increase U/L 0.1 340 670 10 240 60 0.2 4 15 11 10700 / 4 1000 Two- point linear
α-HBDH 405 Kinetic Decrease U/L 0.1 340 546 10 240 60 0.2 4 15 11 1700 / 10 1000 Two- point linear
CK 425 Kinetic Increase U/L 0.1 340 546 5 200 50 / 11 22 11 18000 / 5 1000 Two- point linear
CK-MB 426 Kinetic Increase U/L 0.1 340 670 10 200 50 0.2 11 22 11 11000 / 5 600 Two- point linear
cTnI 477 Endpoint Increase ng/mL 0.01 578 / 25 200 50 / 3 18 19 / / 0.28 10 Logit 4P
IgA 441 Endpoint Increase g/L 0.01 340 / 3 200 100 / -1 10 19 / / 0.2 5.6 Logit 5P
IgA Ⅱ 488 Endpoint Increase g/L 0.01 340 / 3 200 100 / -1 10 19 / / 0.2 8.0 Logit 5P
IgG 443 Endpoint Increase g/L 0.01 670 / 3 200 100 / -1 7 19 / / 0.3 35 Logit 5P
IgM 442 Endpoint Increase g/L 0.01 340 / 3 200 50 / -1 19 19 / / 0.05 4.8 Logit 5P
C3 439 Endpoint Increase g/L 0.01 340 / 3 200 100 / -1 19 19 / / 0.04 3.3 Logit 5P
C4 440 Endpoint Increase g/L 0.001 340 / 3 200 75 / -1 19 19 / / 0.015 0.8 Spline
CRP 429 Endpoint Increase mg/L 0.1 340 / 17 200 50 / -1 19 19 / / 2 150 Logit 5P
CRP Ⅱ 489 Endpoint Increase mg/L 0.1 340 / 8 200 50 / -1 19 19 / / 2 250 Logit 5P
ASO 449 Fixed Time Increase IU/mL 0.1 578 / 4 200 200 / 4 20 8 / / 20 1000 Two- point linear
RF 450 Fixed Time Increase IU/mL 0.01 510 / 6 180 60 / 3 9 8 / / 4 120 Spline
Ca 422 Endpoint Increase mmol/L 0.01 630 / 3 300 / / 0 10 / / / 0.1 3.75 Two- point linear
Mg 423 Endpoint Increase mmol/L 0.01 510 630 3 300 / / 0 19 / / / 0.04 2.05 Two- point linear
Mg II 482 Endpoint Increase mmol/L 0.01 546 630 3 300 / / 0 19 / / / 0.04 2.05 Two- point linear
P 424 Endpoint Increase mmol/L 0.01 340 450 3 300 / / 0 38 / / / 0.3 4.0 Two- point linear

2/3
 Linearity
Pri. Sec. S R1 R2 Linear Reac. Time Incuba. Substrate Antigen
No, Reac. Type Direction Unit Precision Range Limit Rule
Wave Wave （µl） （µl） （µl） Limit Time Limit excess
From To Low Up
P Ⅱ 487 Endpoint Increase mmol/L 0.01 340 670 3 225 75 / -1 19 19 / / 0.3 6.46 Two- point linear
Fe 453 Endpoint Increase μmol/L 0.1 578 670 20 250 50 / -1 19 19 / / 0.9 200 Two- point linear
CO2 451 Fixed Time Decrease mmol/L 0.01 405 510 3 300 / / 4 14 / / / 1 50 Two- point linear
α-AMY 428 Kinetic Increase U/L 0.1 405 578 5 200 50 0.2 4 12 19 22500 / 5 1500 Two- point linear
LIP 448 Kinetic Increase U/L 0.1 578 670 3 300 60 0.2 7 14 10 / / 5 250 Two- point linear
MALB 460 Endpoint Increase mg/L 0.1 340 / 16 250 40 / -1 19 15 / / 4 300 Spline
TRF 462 Endpoint Increase g/L 0.01 340 / 3 300 30 / -1 8 15 / / 0.5 4.5 Spline
ACE 464 Kinetic Decrease U/L 0.1 340 405 16 200 / 0.2 15 30 / / / 12 150 Two- point linear
β-HB 465 Endpoint Increase mmol/L 0.01 510 670 6 200 50 / -1 19 15 / / 0.03 5.5 Two- point linear
G6PD 466 Kinetic Increase U/L 0 340 405 10 200 50 0.2 4 12 15 / / 35 3000 single-point K factor
Precautions and Warnings：
1. G6PD: K factor: 223930.
P/N：0040-20-32370（27.0）

3/3